Summary of Significant Accounting Policies (Details)				1 Months Ended	12 Months Ended
	May 25, 2023 USD ($)	Jul. 30, 2022 USD ($)	Jun. 01, 2021 USD ($)	May 31, 2021 USD ($)	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)	Nov. 30, 2023 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Number of reportable segments | segment					1
Number of operating segments | segment					1
Revenue					$ 65,421,000	$ 45,520,000
Revenue Contractual Period					2 years
Contract balances, account receivable					$ 12,300,000	7,500,000
Deferred revenue					1,090,000	0
Inventory write-downs					196,000	243,000
Impairment of long-lived assets					0	0
Deferred offering costs					387,000	347,000	$ 300,000
Grant period (in years)				5 years
Research and development arrangement with federal government, total budget				$ 9,300,000
Research and development arrangement with federal government, funding for subawards				$ 5,500,000
Approved funding, first year			$ 800,000
Approved funding, including subawards, first year			$ 400,000
Approval for funding, year two	$ 3,000,000	$ 2,600,000
Approval for funding, including subawards, year two	$ 1,500,000	$ 1,600,000
Prepaid expenses and other current assets					2,737,000	3,111,000
Advertising costs					700,000	$ 700,000
International
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Revenue					100,000
Additional Funding Agreement Terms
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Compensation earned					2,000,000
Prepaid expenses and other current assets					$ 100,000
Minimum
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Property, plant and equipment, useful life					3 years
Maximum
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Property, plant and equipment, useful life					5 years